Excess treatment reduction including anthracyclines results in higher incidence of relapse in core binding factor acute myeloid leukemia in children

D. Tomizawa, A. Tawa, T. Watanabe, A. M. Saito, K. Kudo, T. Taga, S. Iwamoto, Akira Shimada, K. Terui, H. Moritake, A. Kinoshita, H. Takahashi, H. Nakayama, K. Koh, H. Kigasawa, Y. Kosaka, H. Miyachi, K. Horibe, T. Nakahata, S. Adachi

Research output: Contribution to journalArticle

30 Citations (Scopus)
Original languageEnglish
Pages (from-to)2413-2416
Number of pages4
JournalLeukemia
Volume27
Issue number12
DOIs
Publication statusPublished - Dec 2013

ASJC Scopus subject areas

  • Hematology
  • Cancer Research
  • Anesthesiology and Pain Medicine

Cite this

Tomizawa, D., Tawa, A., Watanabe, T., Saito, A. M., Kudo, K., Taga, T., Iwamoto, S., Shimada, A., Terui, K., Moritake, H., Kinoshita, A., Takahashi, H., Nakayama, H., Koh, K., Kigasawa, H., Kosaka, Y., Miyachi, H., Horibe, K., Nakahata, T., & Adachi, S. (2013). Excess treatment reduction including anthracyclines results in higher incidence of relapse in core binding factor acute myeloid leukemia in children. Leukemia, 27(12), 2413-2416. https://doi.org/10.1038/leu.2013.153